• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493919920300
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Ventricular Tachycardia (2132); Heart Failure (2206); Ischemic Heart Disease (2493)
Event Date 02/08/2017
Event Type  Death  
Manufacturer Narrative
Device is a combination product.It is indicated that the device will not be returned for evaluation.A review of the manufacturing documentation found that all devices shipped from the batch conformed to the preventive measures / current controls as per the product specifications.The cause of the reported difficulties could not be determined.(b)(4).
 
Event Description
(b)(4) clinical study.Same case as mfr report#: 2134265-2017-09966, 2134265-2017-09967, 2134265-2017-09969.It was reported that following a coronary artery drug eluting stenting treatment procedure, the patient had ventricular tachycardia and expired.In (b)(6) 2013, clinical status assessment identified the patient¿s qualifying condition as stable angina (ccs classification 2).Abnormal fractional flow reserve (ffr) and abnormal stress test or imaging stress test indicated ischemia prior to procedure and the patient was referred for elective cardiac catheterization.Target lesion #1 was located in the mid right coronary artery (mid rca) with 75% stenosis and was 21 mm long with a reference vessel diameter of 3.00 mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00 x 28 mm study stent.Following post-dilatation, residual stenosis was 0%.Target lesion #2 was located in the distal left circumflex artery (lcx) with 80% stenosis and was 20 mm long with a reference vessel diameter of 3.00 mm.Target lesion #2 was treated with pre-dilatation and placement of a 3.00 x 20 mm study stent.Following post-dilatation, residual stenosis was 0%.Target lesion #3 was located in the proximal lcx with 60% stenosis and was 12 mm long with a reference vessel diameter of 3.00 mm.Target lesion #3 was treated with pre-dilatation and placement of a 3.00 x 20 mm study stent and post dilatation was performed.Following post-dilatation there was grade "a" dissection noted which was treated with placement of another 3.00 x 8 mm study stent with 0 % residual stenosis.The patient was discharged on dual antiplatelet therapy the next day.Per death certificate, in (b)(6) 2017, the patient died due to ventricular tachycardia.Immediate cause of death was ventricular tachycardia (1 hour onset to death) and underlying cause of death were heart failure with reduced ejection fraction (2 years onset to death), ischemic heart disease (5 years onset to death) and coronary artery disease (10 years onset to death).Site confirmed that the patient was not admitted to the hospital.The patient was taken to hospital er but passed within one hour of arrival.The patient was given "cardiopulmonary resuscitation" (cpr) as an action taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6959993
MDR Text Key89681054
Report Number2134265-2017-09968
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 09/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/18/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/09/2013
Device Model NumberH7493919920300
Device Lot Number15671416
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/22/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/27/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age61 YR
-
-